Insight on J&J’s TB mass awareness campaign in India
Johnson & Johnson Services has recently taken a TB awareness initiative in India, collaboration with MTV Staying Alive Foundation. The objective is... Read More
Copromotion deal for Japan – Gilead and Eisai in RA therapy filgotinib
Gilead Sciences, Inc and Eisai Co, Ltd announced that Gilead Sciences K.K and Eisai have entered into an agreement for the distribution... Read More
Case study: Novartis to acquire The Medicines Company for $9.7 billion, get hold of inclisiran, a cholesterol drug
Novartis, a one of the leading global pharmaceutical company, to acquire The Medicines Company for $9.7 billion. Strategic reasoning of the deal:... Read More
Insighht on USFDA approval of Trikafta
Vertex Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA). This is a landmark approval where Vertex’s Trikafta earned this... Read More
Alexion acquisition of Achillion: A 1 Billion Pharma Strategic Deal
Posted on21 Oct 2019
TagsAchillion, acquisition in pharma, Alexion Pharmaceuticals, global pharma deals, pharma deal, pharma strategic deal
Comments0
Achillion focuses on the development of oral small-molecule Factor D inhibitors to treat people with rare diseases affecting the ‘complement system’, such... Read More
New Drug Approval Case Study: USFDA approval of Galderma’s Aklief cream
US Food and Drug Administration (FDA) approved Galderma’s Aklief (trifarotene) cream, 0.005% for the topical treatment of acne. Aklief Cream is the... Read More
What is indication splitting licensing in pharmaceutical and bio-pharmaceutical business?
Posted on30 Sep 2019
Comments0
While licensing in pharmaceutical and bio pharmaceutical business, if licenses are issued to different partners based on indications or disease and therapy,... Read More
Pharma acquisition case study: Lundbeck to acquire Alder BioPharmaceuticals for US$ 1.95 billion
H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (Alder) announced a definitive agreement for Lundbeck to acquire Alder. About the deal: Under the... Read More
Mitsubishi Tanabe Pharma, Daiichi Sankyo enters licensing agreement for ALS treatment agent edaravone in Brazil
Posted on18 Sep 2019
Comments0
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo announced that they have concluded a licensing agreement covering commercialization rights in Brazil for an... Read More
GSK to acquire Celiac-Focused Sitari Pharmaceuticals
GlaxoSmithKline will acquire San Diego-based Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for celiac disease. Sitari, a preclinical-stage biotech, is... Read More